Ryan Jeffrey Shaw

Ryan Jeffrey Shaw

Auto-generated profile, based on publicly available information

Ryan Jeffrey Shaw

School of Nursing, Duke University, Durham, North Carolina

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2012 in Health Informatics Journal
Verified
Journal Article
Open access
PDF file
RSRyan Shaw
Ryan Shaw
HBHayden Bosworth
Hayden Bosworth
Nearly 68% of American adults are obese or overweight. Mobile devices such as mobile phones have emerged as a mode of intervention delivery to help people improve their health, particularly in relation to weight loss. This literature review examines the relationship between the use of short message service (SMS) text messaging as an intervention medium and weight loss. Results from this literature review (n = 14) suggest that SMS as an intervention tool for weight loss is still in its infancy. Initial results are promising but continued investigation is needed. We offer several recommendations for future research.

15 July 2014 in Annals of Internal Medicine
Verified
Journal Article
Closed access
PDF file
RSRyan J. Shaw
Ryan J. Shaw
JMJennifer R. McDuffie
Jennifer R. McDuffie
CHCristina C. Hendrix
Cristina C. Hendrix
AEAlison Edie
Alison Edie
LLLinda Lindsey-Davis
Linda Lindsey-Davis
JWJohn W. Williams
John W. Williams
Background: Changes in federal health policy are providing more access to medical care for persons with chronic disease. Providing quality care may require a team approach, which the American College of Physicians calls the “medical home.” One new model may involve nurse-managed protocols. Purpose: To determine whether nurse-managed protocols are effective for outpatient management of adults with diabetes, hypertension, and hyperlipidemia. Data Sources: MEDLINE, Cochrane Central Register of Controlled Trials, EMBASE, and CINAHL from January 1980 through January 2014. Study Selection: Two reviewers used eligibility criteria to assess all titles, abstracts, and full texts and resolved disagreements by discussion or by consulting a third reviewer. Data Extraction: One reviewer did data abstractions and quality assessments, which were confirmed by a second reviewer. Data Synthesis: From 2954 studies, 18 were included. All studies used a registered nurse or equivalent who titrated medications by following a protocol. In a meta-analysis, hemoglobin A1c level decreased by 0.4% (95% CI, 0.1% to 0.7%) (n = 8); systolic and diastolic blood pressure decreased by 3.68 mm Hg (CI, 1.05 to 6.31 mm Hg) and 1.56 mm Hg (CI, 0.36 to 2.76 mm Hg), respectively (n = 12); total cholesterol level decreased by 0.24 mmol/L (9.37 mg/dL) (CI, 0.54-mmol/L decrease to 0.05-mmol/L increase [20.77-mg/dL decrease to 2.02-mg/dL increase]) (n = 9); and low-density-lipoprotein cholesterol level decreased by 0.31 mmol/L (12.07 mg/dL) (CI, 0.73-mmol/L decrease to 0.11-mmol/L increase [28.27-mg/dL decrease to 4.13-mg/dL increase]) (n = 6). Limitation: Studies had limited descriptions of the interventions and protocols used. Conclusion: A team approach that uses nurse-managed protocols may have positive effects on the outpatient management of adults with chronic conditions, such as diabetes, hypertension, and hyperlipidemia. Primary Funding Source: U.S. Department of Veterans Affairs.

1 November 2013 in The American Journal of Medicine
Verified
Journal Article
Closed access
RSRyan J. Shaw
Ryan J. Shaw
HBHayden B. Bosworth
Hayden B. Bosworth
SSSusan S. Silva
Susan S. Silva
ILIsaac M. Lipkus
Isaac M. Lipkus
LDLinda L. Davis
Linda L. Davis
CJConstance M. Johnson
Constance M. Johnson

17 January 2016 in Journal of the American Medical Informatics Association
Verified
Journal Article
Open access
PDF file
RSRyan J Shaw
Ryan J Shaw
DSDori M Steinberg
Dori M Steinberg
JBJonathan Bonnet
Jonathan Bonnet
FMFarhad Modarai
Farhad Modarai
AGAaron George
Aaron George
HBHayden B Bosworth
Hayden B Bosworth
Although mobile health (mHealth) devices offer a unique opportunity to capture patient health data remotely, it is unclear whether patients will consistently use multiple devices simultaneously and/or if chronic disease affects adherence. Three healthy and three chronically ill participants were recruited to provide data on 11 health indicators via four devices and a diet app. The healthy participants averaged overall weekly use of 76%, compared to 16% for those with chronic illnesses. Device adherence declined across all participants during the study. Patients with chronic illnesses, with arguably the most to benefit from advanced (or increased) monitoring, may be less likely to adopt and use these devices compared to healthy individuals. Results suggest device fatigue may be a significant problem. Use of mobile technologies may have the potential to transform care delivery across populations and within individuals over time. However, devices may need to be tailored to meet the specific patient needs.

9 March 2022 in Journal of Medical Internet Research
Verified
Journal Article
Open access
ZNZhao Ni
Zhao Ni
BWBei Wu
Bei Wu
QYQing Yang
Qing Yang
LYLijing Yan
Lijing Yan
KLKa Li
Ka Li
RSRyan J Shaw
Ryan J Shaw
Background: The treatment of many chronic illnesses involves long-term pharmaceutical therapy, but it is an ongoing challenge to find effective ways to improve medication adherence to promote good health outcomes. Cardioprotective medications can prevent the enlargement of harmful clots, cardiovascular symptoms, and poor therapeutic outcomes, such as uncontrolled high blood pressure and hyperlipidemia, for patients with coronary heart disease. Poor adherence to cardioprotective medications, however, has been reported as a global health concern among patients with coronary heart disease, and it is particularly a concern in China. Objective: This study aimed to evaluate the efficacy of a mobile health (mHealth) intervention using 2 mobile apps to improve medication adherence and health outcomes. Methods: A randomized, placebo-controlled, 2-arm parallel study was conducted in a major university-affiliated medical center located in Chengdu, China. Participants were recruited by flyers and health care provider referrals. Each participant was observed for 90 days, including a 60-day period of mHealth intervention and a 30-day period of nonintervention follow-up. The study coordinator used WeChat and Message Express to send educational materials and reminders to take medication, respectively. Participants used WeChat to receive both the educational materials and reminders. Participants in the control group only received educational materials. This study received ethics approval from the Duke Health Institutional Review Board (Pro00073395) on May 5, 2018, and was approved by West China Hospital (20170331180037). Recruitment began on May 20, 2018. The pilot phase of this study was registered on June 8, 2016, and the current, larger-scale study was retrospectively registered on January 11, 2021 (ClinicalTrials.gov). Results: We recruited 230 patients with coronary heart disease. Of these patients, 196 completed the baseline survey and received the intervention. The majority of participants were married (181/196, 92.4%), male (157/196, 80.1%), and lived in urban China (161/196, 82.1%). Participants’ average age was 61 years, and half were retired (103/191, 53.9%). More than half the participants (121/196, 61.7%) were prescribed at least 5 medications. The mean decrease in medication nonadherence score was statistically significant at both 60 days (t179=2.04, P=.04) and 90 days (t155=3.48, P<.001). Systolic blood pressure and diastolic blood pressure decreased in the experimental group but increased in the control group. The mean decrease in diastolic blood pressure was statistically significant at both 60 days (t160=2.07, P=.04) and 90 days (t164=2.21, P=.03). The mean decrease in systolic blood pressure was significantly different in the groups at 90 days (t165=3.12, P=.002). Conclusions: The proposed mHealth intervention can improve medication adherence and health outcomes, including systolic blood pressure and diastolic blood pressure. Trial Registration: ClinicalTrials.gov NCT02793830; https://clinicaltrials.gov/ct2/show/NCT02793830 and ClinicalTrials.gov NCT04703439; https://clinicaltrials.gov/ct2/show/NCT04703439

7 May 2013 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
RSRyan J Shaw
Ryan J Shaw
HBHayden B Bosworth
Hayden B Bosworth
JHJeffrey C Hess
Jeffrey C Hess
SSSusan G Silva
Susan G Silva
ILIsaac M Lipkus
Isaac M Lipkus
CJConstance M Johnson
Constance M Johnson
Development of a Theoretically Driven mHealth Text Messaging Application for Sustaining Recent Weight Loss